Log In
Print this Print this

SCX-001 (formerly MI-001)

  Manage Alerts
Collapse Summary General Information
Company ScarX Therapeutics Inc.
DescriptionTopical anti-scarring agent
Molecular Target Beta-catenin (CTNNB1)
Mechanism of ActionBeta-catenin antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationScars / wrinkles
Indication DetailsTreat and prevent post-surgical scarring
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today